dQM CMS Content Implementation Guide
2026.1.0 - CI Build

dQM CMS Content Implementation Guide, published by cqframework. This guide is not an authorized publication; it is the continuous build for version 2026.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/dqm-content-cms-2026/ and changes regularly. See the Directory of published versions

Library: NCT01980823 Eligibility Criteria

Official URL: https://research.balgrist.ch/Library/NCT01980823EligibilityCriteria Version: 1.0.0
Active as of 2026-05-17 Computable Name: NCT01980823EligibilityCriteria

NCT01980823 Eligibility Criteria

Metadata
Title NCT01980823 Eligibility Criteria
Version 1.0.0
Topic FHIR
Topic CQL
Description

NCT01980823 Eligibility Criteria

Type logic-library from http://terminology.hl7.org/CodeSystem/library-type
Parameter Name: Patient
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: Patient
Parameter Name: Is Female
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Has Histologically Confirmed Breast Cancer or DCIS
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Has Operable Tumor With Planned Surgical Excision
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Tumor Size At Least 5mm
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Is At Least 21 Years Old
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: No Prior Treatment Within 6 Months
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Has Acceptable ECOG Status
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Has Signed Informed Consent
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: On Diabetes Or Hypercholesterolemia Medication
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: On Investigational Drug Within 6 Months
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: On Strong CYP3A4 Inhibitor
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Has Renal Impairment
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Has Gilberts Syndrome
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Has Hepatic Impairment
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Meets Inclusion Criteria
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Meets Exclusion Criteria
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Parameter Name: Is Eligible
Use: Out
Min Cardinality: 0
Max Cardinality: 1
Type: boolean
Data Requirement Type: Condition
Profile(s): Condition
Code Filter(s):
Path: code
Code(s): SNOMED CT: 254838004 (Carcinoma of breast)
Data Requirement Type: Observation
Profile(s): Observation
Code Filter(s):
Path: code
ValueSet: Tumor Size Observations
Data Requirement Type: Procedure
Profile(s): Procedure
Data Requirement Type: Observation
Profile(s): Observation
Code Filter(s):
Path: code
Code(s): LOINC: 89247-1 (ECOG Performance Status score)
Data Requirement Type: Consent
Profile(s): Consent
Data Requirement Type: Observation
Profile(s): Observation
Code Filter(s):
Path: code
Code(s): SNOMED CT: 713670002 (Entered into drug clinical trial)
Data Requirement Type: MedicationRequest
Profile(s): MedicationRequest
Data Requirement Type: Observation
Profile(s): Observation
Code Filter(s):
Path: code
ValueSet: Serum Creatinine Lab Tests
Data Requirement Type: Observation
Profile(s): Observation
Code Filter(s):
Path: code
ValueSet: Aspartate Transaminase (AST/SGOT) Lab Tests
Data Requirement Type: Observation
Profile(s): Observation
Code Filter(s):
Path: code
ValueSet: Alanine Transaminase (ALT/SGPT) Lab Tests
Data Requirement Type: Observation
Profile(s): Observation
Code Filter(s):
Path: code
ValueSet: Total Bilirubin Lab Tests
Data Requirement Type: Observation
Profile(s): Observation
Code Filter(s):
Path: code
ValueSet: Alkaline Phosphatase Lab Tests
Library Content
CQL Content
library NCT01980823EligibilityCriteria version '1.0.0'

using FHIR version '4.0.1'

include hl7.fhir.uv.cql.FHIRHelpers version '4.0.1' called FHIRHelpers
include hl7.fhir.uv.cql.FHIRCommon version '2.0.0' called FHIRCommon

codesystem "SNOMED-CT": 'http://snomed.info/sct'
codesystem "LOINC": 'http://loinc.org'

// --- VALUESETS ---

valueset "Chemotherapy or Radiation or Breast Resection Codes":
  'https://example.org/fhir/ValueSet/chemo-radiation-breast-resection'

valueset "Diabetes or Hypercholesterolemia Medications":
  'https://example.org/fhir/ValueSet/diabetes-hypercholesterolemia-medications'

valueset "Strong CYP3A4 Inhibitor Medications":
  'https://example.org/fhir/ValueSet/strong-cyp3a4-inhibitors'

valueset "Serum creatinine":
  'https://example.org/fhir/ValueSet/serum-creatinine'
  //'https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.526.3.1139'

valueset "AST":
  'https://example.org/fhir/ValueSet/ast-lab-tests'

valueset "ALT":
  'https://example.org/fhir/ValueSet/alt-lab-tests'

valueset "Total Bilirubin":
  'https://example.org/fhir/ValueSet/total-bilirubin'

valueset "Alkaline Phosphatase":
  'https://example.org/fhir/ValueSet/alkaline-phosphatase'

valueset "Core needle biopsy":
  'https://example.org/fhir/ValueSet/core-needle-biopsy'

valueset "Histologic test":
  'https://example.org/fhir/ValueSet/histologic-test'

valueset "Tumor Size Observations":
  'https://example.org/fhir/ValueSet/tumor-size-observations'

 
// --- CODES ---

code "Female": '248152002' from "SNOMED-CT" display 'Female (finding)'
code "Carcinoma of breast": '254838004' from "SNOMED-CT" display 'Carcinoma of breast'
code "ECOG Performance Status": '89247-1' from "LOINC" display 'ECOG Performance Status score'
code "Informed consent given": '203031000000107' from "SNOMED-CT" display 'Informed consent given'
code "Entered into drug clinical trial": '713670002' from "SNOMED-CT" display 'Entered into drug clinical trial'

// --- CONTEXT ---

context Patient

// ===========================
// INCLUSION CRITERIA
// ===========================

// 1. Female
define "Is Female":
  Patient.gender = 'female'

// 2. Histologically confirmed invasive breast cancer or DCIS
define "Has Histologically Confirmed Breast Cancer or DCIS":
  exists (
    [Condition: "Carcinoma of breast"] C
      where C.verificationStatus ~ FHIRCommon."confirmed"
        and exists (
          C.evidence E
            where E.code in "Histologic test"
        )
  )

// 3. Operable tumor with core needle biopsy followed by surgical excision >= 2 weeks after enrollment
define "Has Operable Tumor With Planned Surgical Excision":
  exists (
    [Procedure: "Core needle biopsy"] P
      where P.status = 'completed'
  )
  // Surgical excision timing (>= 2 weeks post-enrollment) assumed tracked externally

// 4. Tumor size >= 5 mm by imaging or pathology
define "Tumor Size At Least 5mm":
  exists (
    [Observation: "Tumor Size Observations"] O
      where O.status in { 'final', 'amended' }
        and (O.value as FHIR.Quantity) >= 5 'mm'
  )

// 5. Age >= 21 years
define "Is At Least 21 Years Old":
  AgeInYears() >= 21

// 6. No prior chemo, radiation, or breast resection within 6 months of study entry
define "No Prior Treatment Within 6 Months":
  not exists (
    [Procedure] P
      where P.status = 'completed'
        and P.code in "Chemotherapy or Radiation or Breast Resection Codes"
        and P.performed.toInterval() ends 6 months or less before Today()
  )

// 7. ECOG Performance Status 0-1
define "Has Acceptable ECOG Status":
  exists (
    [Observation: "ECOG Performance Status"] O
      where O.status in { 'final', 'amended' }
        and (O.value as FHIR.integer) in Interval[0, 1]
  )

// 8. Signed informed consent
define "Has Signed Informed Consent":
  exists (
    [Consent] C
      where C.status = 'active'
  )

// ===========================
// EXCLUSION CRITERIA
// ===========================

// 9. Currently on medication for diabetes or hypercholesterolemia
define "On Diabetes Or Hypercholesterolemia Medication":
  exists (
    [MedicationRequest] M
      where M.status = 'active'
        and M.medication in "Diabetes or Hypercholesterolemia Medications"
  )

// 10. Treatment with investigational drugs within 6 months
define "On Investigational Drug Within 6 Months":
  exists (
    [Observation: "Entered into drug clinical trial"] O
      where O.effective ends 6 months or less before Today()
  )

// 11. Strong CYP3A4 inhibitor use (e.g. clarithromycin, HIV protease inhibitors, itraconazole)
define "On Strong CYP3A4 Inhibitor":
  exists (
    [MedicationRequest] M
      where M.status = 'active'
        and M.medication in "Strong CYP3A4 Inhibitor Medications"
  )

// 12. Renal impairment: creatinine > 1.4 mg/dL
define "Has Renal Impairment":
  exists (
    [Observation: "Serum creatinine"] O
      where O.status in { 'final', 'amended' }
        and (O.value as FHIR.Quantity) > 1.4 'mg/dL'
  )

// TODO: Define Gilberts Syndrome
define "Has Gilberts Syndrome":
  false

define fluent function "Upper Limit of Normal"(O Observation):
  if exists(O.referenceRange) then
    O.referenceRange[0].high
  else
    null

// 13. Hepatic impairment
define "Has Hepatic Impairment":
  exists (
    [Observation: "AST"] O
      where (O.value as FHIR.Quantity) >= 2.5 * O."Upper Limit of Normal"()
  )
  or exists (
    [Observation: "ALT"] O
      where (O.value as FHIR.Quantity) >= 2.5 * O."Upper Limit of Normal"()
  )
  or exists (
    [Observation: "Total Bilirubin"] O
      where (O.value as FHIR.Quantity) >= 1.5 * O."Upper Limit of Normal"()
        and not "Has Gilberts Syndrome"
  )
  or exists (
    [Observation: "Alkaline Phosphatase"] O
      where (O.value as FHIR.Quantity) > 2.5 * O."Upper Limit of Normal"()
  )

// ===========================
// COMPOSITE ELIGIBILITY
// ===========================

define "Meets Inclusion Criteria":
  "Is Female"
    and "Has Histologically Confirmed Breast Cancer or DCIS"
    and "Has Operable Tumor With Planned Surgical Excision"
    and "Tumor Size At Least 5mm"
    and "Is At Least 21 Years Old"
    and "No Prior Treatment Within 6 Months"
    and "Has Acceptable ECOG Status"
    and "Has Signed Informed Consent"

define "Meets Exclusion Criteria":
  "On Diabetes Or Hypercholesterolemia Medication"
    or "On Investigational Drug Within 6 Months"
    or "On Strong CYP3A4 Inhibitor"
    or "Has Renal Impairment"
    or "Has Hepatic Impairment"

define "Is Eligible":
  "Meets Inclusion Criteria"
    and not "Meets Exclusion Criteria"
ELM XML Content
Encoded data (176168 characters)
ELM JSON Content
Encoded data (347016 characters)
Generated using version 0.5.0 of the sample-content-ig Liquid templates